Diligence memo · auto-generated · as of July 2, 2026
Conceivable Life Sciences Inc.
Conceivable Life Sciences Inc. looks over-valued against its niche peers and is active on financing cadence.
Businessfiled
Conceivable Life Sciences Inc. operates in Other Health Care, based in NEW YORK.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Conceivable Life Sciences Inc. has raised $63M in disclosed capital across 3 recorded rounds, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).
Largest single filing: $30M on 2025-08-05.
Most recent recorded round closed around 2025-08-05.
Valuation (modeled)modeled
Provath models Conceivable Life Sciences Inc. at approximately $143M (range $72M–$207M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Over-valued. Modeled value is 1.55× the median modeled value of Series B Other Health Care companies in 2025–2027 (48 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 8 months.
Last raise 11 mo ago; this sector typically re-raises about every 14 months.
Raising on or ahead of the sector's normal rhythm.
The last round stepped up 2.0× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 94% of Other Health Care peers (5377 compared).
Modeled value ranks above 84% of those peers.
Closest niche peers: Imagine Pediatrics Holdings LLC, Porter Cares, Inc., True Medicine Inc., CranioVation, Inc., Seriously Clean LTD..
Peoplefiled
7 named people on file across officers, directors and signatories.
Risks & flagsmixed
Modeled above niche peers — valuation risk on entry.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.